Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net Sales	$ 5,875,611	$ 3,551,564	$ 15,139,347	$ 7,748,499
Cost of Goods Sold	5,036,997	2,500,163	11,847,842	5,231,155
Gross Profit	838,614	1,051,401	3,291,505	2,517,344
Operating Expenses
Research and development	93,522	0	234,885	53,408
Selling general and administrative expenses	3,505,097	2,683,025	10,637,538	6,991,472
Loss on impairment of goodwill	0	0	1,138,203	0
Total Operating Expenses	3,598,619	2,683,025	12,010,626	7,044,880
Operating Loss	(2,760,005)	(1,631,624)	(8,719,121)	(4,527,536)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	34,804	151,570	46,521	(148,882)
Interest expense	(43,037)	0	(96,113)	0
Loss on change in Fair Market Value of Contingent Consideration	0	0	(240,000)	0
Gain on Settlement of Contingent Consideration (Note 2)	0	0	1,700,000	0
Other Income	67,765	1,068	69,713	26,250
Forgiveness of paycheck protection program loan	0	296,827	0	296,827
Total Other Income (Expense)	59,532	449,465	1,480,121	174,195
Loss Before Provision for Income Taxes	(2,700,473)	(1,182,159)	(7,239,000)	(4,353,341)
Benefit from Income Taxes	0	(101,354)	0	(101,354)
Net Loss	(2,700,473)	(1,080,805)	(7,239,000)	(4,251,987)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(362,250)	(241,500)	(1,086,750)	(241,500)
Net Loss attributable to common stockholders	$ (3,062,723)	$ (1,322,305)	$ (8,325,750)	$ (4,493,487)
Basic and Diluted Loss Per Common Share	$ (0.24)	$ (0.14)	$ (0.65)	$ (0.48)
Weighted Average Shares Outstanding - basic and diluted	12,656,093	9,421,908	12,751,360	9,282,675